ARS Pharmaceuticals, Inc. - Common Stock — 분기별 현금 흐름 (NASDAQ:SPRY) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 351.15 M327.32 M313.47 M372.8 M327.65 M287.57 M 총 부채 94.36 M98.34 M121.15 M225.15 M213.39 M226.26 M 자본금 총액 256.8 M228.97 M192.32 M147.66 M114.26 M61.31 M 총 부채 및 주주자본 351.15 M327.32 M313.47 M372.8 M327.65 M287.57 M 총부채 —————— 순부채 ——————

뉴스

다우 지수, 금리인상 우려로 500p 이상 하락···투자 심리 위축, 공포 지수 '탐욕' 영역

ARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call Transcript

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimates

다우 지수 5만 포인트 돌파 마감···투자 심리 개선, 공포 지수는 '탐욕' 영역

ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most A

Eton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimates

Merck KGaA (MKKGY) Surpasses Q1 Earnings and Revenue Estimates

Cronos Group (CRON) Q1 Earnings Meet Estimates

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat Estimates

Earnings Preview: ARS Pharmaceuticals, Inc. (SPRY) Q1 Earnings Expected to Decline

ARS Pharmaceuticals, Inc. (SPRY) Soars 7.1%: Is Further Upside Left in the Stock?

ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)